D. Neil Hayes to lead OSUCCC’s Institute for Precision Cancer Medicine

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research.

July 10, 2026

Vol.52 No.27

By Enrique Velazquez-Villarreal

Clinical Roundup

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

For years, a central debate in tobacco policy has been whether taxing e-cigarettes might unintentionally drive vapers back to traditional cigarettes.

April 17, 2026

Vol.52 No.15

Clinical Trials & Tribulations

Protecting the cure: Why the future of radiation oncology must be precision-guided

Radiation therapy has been a cornerstone of cancer care since 1896. For more than a century, the central challenge has remained unchanged: How to eradicate tumors while preserving the normal tissues that allow patients not only to survive, but to thrive after treatment.

April 10, 2026

Vol.52 No.14

By J. Isabelle Choi

Clinical Trials & Tribulations

Early-onset cancer is on the rise. Here is how OSUCCC–James is adapting to the needs of younger patients

The incidence of multiple cancer types in people under the age of 50 has been rising, with early-onset cancers now contributing to nearly 15,000 excess cases of cancer in the U.S. annually.

March 27, 2026

Vol.52 No.12

By W. Kimryn Rathmell

In Brief

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

W. Kimryn Rathmell, CEO of the James Cancer Hospital and Solove Research Institute, has also been named director of The Ohio State University Comprehensive Cancer Center in place of former Director Raphael E. Pollock, who has stepped down from the position he had held since November 2017 to become OSUCCC director emeritus.

March 06, 2026

Vol.52 No.09

In Brief

Alice Soragni joins CU Anschutz to launch functional personalized medicine initiative

Alice Soragni, an expert in patient-derived tumor organoids and functional precision oncology, has joined the University of Colorado Anschutz.

February 20, 2026

Vol.52 No.07

D. Neil Hayes to lead OSUCCC’s Institute for Precision Cancer Medicine

YOU MAY BE INTERESTED IN

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

Protecting the cure: Why the future of radiation oncology must be precision-guided

Early-onset cancer is on the rise. Here is how OSUCCC–James is adapting to the needs of younger patients

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

Alice Soragni joins CU Anschutz to launch functional personalized medicine initiative

Renew today!

Subscriber content

Never miss an issue!

Login

D. Neil Hayes to lead OSUCCC’s Institute for Precision Cancer Medicine

YOU MAY BE INTERESTED IN

The challenge of making the move from conversational AI to autonomous scientific discoveryAdvancing from level II to level III AI agents in precision medicine

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

Protecting the cure: Why the future of radiation oncology must be precision-guided

Early-onset cancer is on the rise. Here is how OSUCCC–James is adapting to the needs of younger patients

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

Alice Soragni joins CU Anschutz to launch functional personalized medicine initiative

Never miss an issue!

Login

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine